Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Exact Sciences Corp
EXAS
Healthcare
Biotechnology
Exact Sciences Corporation is a provider of cancer screening and diagnostic tests. The Company provides a portfolio of products for earlier cancer detection and treatment guidance. Its products and services focus on screening and precision oncology tests. It is focusing its research and development efforts on three main areas: Colorectal Cancer Screening Test Development, MCED Test Development...
and MRD Test Development. Its products and services include Cologuard test, Oncotype DX Breast Recurrence Score Test, Oncotype DX Breast DCIS Score Test, Oncotype DX Colon Recurrence Score Test, OncoExTra Test, and Riskguard Test. Its flagship screening product, the Cologuard test, is a non-invasive, stool-based deoxyribonucleic acid (sDNA) screening test that utilizes a multi-target approach to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. The Oncotype DX Breast Recurrence Score test examines the activity of 21 genes in a patient’s breast tumor tissue.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:EXAS)
New Post
View:
Posts & Comments
Threaded Posts
(323)
•••
IainCaimbeul
X
Comment by
IainCaimbeul
on Apr 04, 2022 7:36pm
RE:Szls will eat Exas’ lunch
Can you imagine what the stock price would be if we were 2nd or 3rd?
(13)
•••
Mykndrsn
X
Post by
Mykndrsn
on Jun 19, 2021 4:49pm
Szls will eat Exas’ lunch
First in liquid biopsy. Exas is years behind.
(14)
•••
LeoSeducer67
X
Comment by
LeoSeducer67
on Oct 27, 2020 10:04am
RE:Looks like szls could be a real threat
Recognition will come to szls soon enough.
(79)
•••
Choosesisely777
X
Post by
Choosesisely777
on Oct 12, 2019 12:57pm
Looks like szls could be a real threat
To Exas .coming soon 11 cancers detected with single drop of blood .No need to handle poop .
(558)
•••
FacBine
X
Post by
FacBine
on Oct 11, 2019 10:42pm
StageZero Life Sciences Enters European Market
StageZero Life Sciences Enters European Market with Oncore Pharma and BodyCheck NL; Multi-Year Agreement Valued at US$40 million. Read more at: https://www.stagezerolifesciences.com/latestnews.html
(558)
•••
FacBine
X
Comment by
FacBine
on Sep 25, 2019 4:41pm
RE:RE:SZLS
Are you invested here SGordony???? I didn't think so, cause this is not a penny stock :)))))))) go play with your peny....:))))))))))
(171)
•••
SGordon
X
Comment by
SGordon
on Sep 25, 2019 4:09pm
RE:SZLS
Wrong board pumper!! ;)
(558)
•••
FacBine
X
Post by
FacBine
on Sep 25, 2019 1:22pm
SZLS
https://www.stagezerolifesciences.com/prostate-health-index.html
(171)
•••
SGordon
X
Comment by
SGordon
on Sep 21, 2019 11:26am
RE:Iam afraid
Don't be afraid, you have no share in EXAS!! ;)
(79)
•••
Choosesisely777
X
Post by
Choosesisely777
on Sep 10, 2019 11:00am
Iam afraid
Szls test cost 375 compared to our test at 650 .could szls wipe us off the map.
(558)
•••
FacBine
X
Post by
FacBine
on Aug 11, 2019 9:38am
Aristotle™ - 1 Test - 10 Cancers - Unlimited Possibilities
StageZero Life Sciences : Colorectal, Prostate, Cervical, Endometrial, Breast, Ovarian, Liver, Bladder, Nasopharyngeal, and Stomach Cancer. StageZero Life Sciences, one of the pioneers of the liquid
...more
(3076)
•••
Goldy63
X
Post by
Goldy63
on Mar 07, 2019 7:41am
Gen . Read This . Much Better Deal And Cheap For Now
An increase of close to 500%....Why??? In the last 2 months an increase of approximately 500% in SP value... the question is why??? One reason could be that the Genenews we see today is a
...more
(56)
•••
jomby
X
Post by
jomby
on Mar 01, 2019 8:46pm
GEN
9,000,000 shares traded.today still only 16.5 cents and no news yet. https://stockhouse.com/companies/quote?symbol=t.gen
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Healthcare and Clinical Stage Drug Development Company Acquires NoBrainer Imaging Centers